Literature DB >> 22248319

Huntington's disease: advocacy driving science.

Nancy S Wexler1.   

Abstract

My mother, Leonore, was diagnosed with Huntington's disease (HD) in 1968 at age 53. I was 23, my sister Alice 26, and our father, Milton Wexler, 60 years old. The same year, our father created the Hereditary Disease Foundation (HDF), dedicated to finding treatments and cures for HD. HD is an autosomal dominant, neurodegenerative disorder. Alice and I each have a 50% chance of inheriting and dying from the disorder. Over the past 43 years, we have been proud to change the face of science. Through Milton Wexler Interdisciplinary Workshops, judicious funding, and focusing on innovation and creativity, the HDF is an integral partner in key discoveries. The HDF recruited and supported >100 scientists worldwide who worked together as the Huntington's Disease Collaborative Research Group in a successful ten-year search for the HD gene. We found a DNA marker for the HD gene in 1983-the first marker to be found when the chromosomal location was unknown. We isolated the HD gene itself a decade later. These breakthroughs helped launch the Human Genome Project. We supported creating the first mouse model of HD and many other model systems. Currently, we focus on gene silencing, among other approaches, to create new treatments and cures.

Entities:  

Mesh:

Year:  2012        PMID: 22248319     DOI: 10.1146/annurev-med-050710-134457

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  14 in total

1.  Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer.

Authors:  Ellen Sapp; Antonio Valencia; Xueyi Li; Neil Aronin; Kimberly B Kegel; Jean-Paul Vonsattel; Anne B Young; Nancy Wexler; Marian DiFiglia
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

Review 2.  The role of brain tumor advocacy groups.

Authors:  Michele Rhee; Paulius Mui; Carl Cadogan; Jonny Imerman; Sarah Lindsell; Lainey Titus Samant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 3.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

Review 4.  Strategies for more rapid translation of cellular therapies for children: a US perspective.

Authors:  Rosa Sanchez; Leslie E Silberstein; Robert W Lindblad; Lisbeth A Welniak; Traci Heath Mondoro; John E Wagner
Journal:  Pediatrics       Date:  2013-07-08       Impact factor: 7.124

5.  Personalized genomic disease risk of volunteers.

Authors:  Manuel L Gonzalez-Garay; Amy L McGuire; Stacey Pereira; C Thomas Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

6.  Patient and interest organizations' views on personalized medicine: a qualitative study.

Authors:  Isabelle Budin-Ljøsne; Jennifer R Harris
Journal:  BMC Med Ethics       Date:  2016-05-13       Impact factor: 2.652

7.  Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.

Authors:  Kathryn R Bowles; Simon P Brooks; Stephen B Dunnett; Lesley Jones
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

8.  Highlights of the DNA cutters: a short history of the restriction enzymes.

Authors:  Wil A M Loenen; David T F Dryden; Elisabeth A Raleigh; Geoffrey G Wilson; Noreen E Murray
Journal:  Nucleic Acids Res       Date:  2013-10-18       Impact factor: 16.971

9.  Juvenile Huntington's disease: a population-based study using the General Practice Research Database.

Authors:  Ian Douglas; Stephen Evans; Michael D Rawlins; Liam Smeeth; Sarah J Tabrizi; Nancy S Wexler
Journal:  BMJ Open       Date:  2013-04-03       Impact factor: 2.692

10.  Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.

Authors:  Stephen J W Evans; Ian Douglas; Michael D Rawlins; Nancy S Wexler; Sarah J Tabrizi; Liam Smeeth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.